South Metro Theraplay New Prague, MN - 56071

South Metro Theraplay is categorized under Speech Pathologists in New Prague, MN and active since 2007.

South Metro Theraplay was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Speech Pathologists business, which does work in the B2C market, and is classified as a Speech Pathologists, under code number 6213300 by the NAICS.

If you are seeking more information, feel free to contact Andrea Malecha, Owner at the company’s single location by writing to 314 Main St East # 3, New Prague, Minnesota MN 56071 or by phoning (952) 758-5775. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: South Metro Theraplay
Contact Person: Andrea Malecha, Owner
Address: 314 Main St East # 3, New Prague, Minnesota 56071
Phone Number: (952) 758-5775
Website Address: southmetrotheraplay.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Speech Pathologists
SIC Code: 8049
NAICS Code: 6213300
Share This Business:

South Metro Theraplay was started in 2007 to provide professional Speech Pathologists under the SIC code 8049 and NAICS code 6213300. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Andrea Malecha, Owner for inquiries that concern South Metro Theraplay by calling the company number (952) 758-5775, as your correspondence is most welcome. Additionally, the physical location of the single location of South Metro Theraplay can be found at the coordinates 44.543517,-93.573057 as well as the street address 314 Main St East # 3 in New Prague, Minnesota 56071.

For its online presence, you may visit South Metro Theraplay’s website at southmetrotheraplay.com and engage with its social media outlets through on Twitter and on Facebook.